A Study Of GW406381 In Volunteers With Moderate Hepatic Impairment

NCT00373243 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain

Interventions

DRUG: GW406381

Sponsor

GlaxoSmithKline